BIO-TECHNE Corp — Director's Dealing 2016

Sep 12, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2016-09-08

Reporting Person: HIGGINS JOHN L (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-09-08	Common Stock	S	1700	$109.8329	Disposed	1359	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$87.34	2025-10-28	Common Stock (4260)	4260	Direct
Stock Option (right to buy)	$91.78	2024-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$87.39	2023-10-30	Common Stock (4000)	4000	Direct
Stock Option (right to buy)	$66.90	2022-10-24	CommonS tock (5000)	5000	Direct
Stock Option (right to buy)	$70.35	2021-10-26	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$61.46	2020-10-27	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$63.03	2019-10-28	Common Stock (5000)	5000	Direct
Stock Option (right to buy)	$61.08	2019-05-19	Common Stock (10000)	10000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.35 to $110.2867 inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.